GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] proposal — a flair for state board posts — 67 comments in the full submission. View in context.
1.6k
c/compounding·submitted 11 months ago by u/jonas_eriksen

[Meta] proposal — a flair for state board posts

Pricingbranch of 7 comments

proposal — a flair for state board posts. Disagreement welcome, but bring a concrete alternative wording. The five questions worth asking before you commit to any compounded arrangement. Which facility, by name. Whether it is a 503A pharmacy or a 503B outsourcing facility. What concentration is on the label. What the…

Read the full submission and all 67 comments →

This branch

7 comments, started 11 months ago
u/elise_ramos-6 points·11 months ago

What is the beyond-use date and what is it based on?

replysharereportpermalink
u/marit_laurent1 point·11 months ago

Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.

replysharereportpermalink
u/niels_roos1 point·11 months ago

ask which facility, then ask for their testing

replysharereportpermalink
u/burned_once_twice0 points·11 months ago

ask which facility, then ask for their testing

Adding one thing — ask for the facility name. Most will give it, and the ones that will not have answered you.

replysharereportpermalink
u/clara_danquah0 points·11 months ago

Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.

replysharereportpermalink
u/burned_once_twice1 point·11 months ago·edited

if a clinic will not name the facility, that is your answer

replysharereportpermalink
u/ireland_drugs_pay1 point·11 months ago·edited

Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →